Granisetron Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 3.1 mg patch
Reference Brands: Sancuso
Category:
Transdermal Patches
Granisetron patches deliver a selective serotonin 5-HT3 receptor antagonist, blocking nausea and vomiting signals in the brain and gut. Benefits include sustained, convenient drug delivery, effective prevention of chemotherapy- and radiation-induced nausea, and improved patient comfort, supporting better treatment adherence and quality of life in cancer care.
Granisetron Patch is available in Patches
and strengths such as 3.1 mg patch.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Granisetron Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Granisetron Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Granisetron patches are regulated in the EU and US, with dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to reliable, effective antiemetic therapy supporting cancer patients worldwide, improving treatment comfort, adherence, and quality of life during chemotherapy and radiation therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing